Download agenda here for complete speaker list

EXTERNAL STAKEHOLDERS

Deputy Regional Medical Director
NHS England North

Clinical professor
Rutgers State University of New jersey,
Director of Pharmacy Strategy and Clinical Integration
Horizon Blue Cross Blue Shield of New Jersey, USA

Treatment Information and Access Director, Health Policy Advisor
EURORDIS

President, 
European Medical Association

Vice President of Innovation
PatientsLikeMe

Research Professor of Medicine
The University Hospital of Catania

Consumer Lead, Chair, Consumer Forum
National Cancer Research Institute

Senior Vice President & Secretary General, 
European Society for Person Centered Healthcare (ESPCH)

President
European Union of Private Hospitals, (UEPH)

Advisor to the President, Director, International Affairs
HAS, Haute Autorité de Santé, France (TBC)

Honorary Industrial Ambassador in Regulatory Science
The University of Copenhagen, Denmark

CEO
Patient View

Director General, European Confederation of Pharmaceutical Entrepreneurs
Partner,  NOVACOS Law, Germany

Director, Technical Communication and Strategy
Wolfram Research

INDUSTRY: 

Chief Financial Officer
UCB

Vice President, Head of Operations and Payer Intelligence, Global Market Access
Sanofi

Global Head Operations, Payer & Real World Evidence
AstraZeneca

Director of Real World Evidence, Global Patient Outcomes and Real World Evidence, International
Eli Lilly and Company

Senior Medical Officer, Vice President, Global Medical Affairs
Sanofi

Scientific Director, RMEDS, Quantitative Sciences
Janssen

Global Head of Real World, Evidence Solutions
Novartis

SVP, Head of Clinical Development,
BTG International

Vice President, Head Global Clinical Science & Operations
UCB

Head Patient Relations
Bayer

Vice President, Medical Affairs
Norgine

Senior Vice President, Global Patient Solutions,
Teva

VP, Head of Region Europe
Value Demonstration & Access
Shire International

 

Download agenda here for complete speaker list
Download agenda here for complete speaker list

PHARMA & BIOTECH INDUSTRY EXPERTS

Vice President, Global Patient Centered Outcomes and Solutions
Sanofi, USA

Senior Vice President Global Patient Solutions
Teva, Netherlands

Head of Medical Affairs-Primary Care & Women's Health
Merck, USA

Vice President, Medical Affairs
Norgine, UK

Head of DCV Medical Operations
Sanofi, Japan

Senior Medical Director Germany Medical Lead Internal Medicine
Pfizer, Germany 

Director, Medical Science
ValeantPharmaceuticals, USA

Associate Director Global Medical Communications
Shire, Switzerland

Regional Medical Director, Emerging Growth Markets
Novartis, Switzerland

Director, Global Medical Information
Biogen, Switzerland

Medical Lead for Diabetology and Cardiovascular Portfolio, CEE Region
MSD, Poland

EU Medical Director
Norgine, UK

Medical Director
BMS, Romania

Director Global Outcomes Research,
Takeda, UK

 

MedTech Industry Experts

Vice President, Corporate Medical Safety Strategic Scientific Operations,
Medtronic, USA

Medical Affairs Lead, Medical Devices EMEA
Johnson & Johnson, UK

Director, Medical Affairs, Structural Heart EMEA
Abbott Vascular, Belgium

Global Scientific Communications Director, Medical Affairs
Medtronic, France

Head of Clinical Science Support
Geistlich, Switzerland

 

Patients & Stakeholders

Senior Vice President & Secretary General,
European Society for Person Centered Healthcare (ESPCH),
Editor-in-Chief,
European Journal for Person Centered Healthcare & Journal of Evaluation in Clinical Practice, Spain

Consumer Lead, Chair Consumer Forum
National Cancer Research Institute, UK

President
European Medical Association, Belgium

Head of the Centre for Clinical Trials
Witten/Herdecke University, Germany

Vice President of Innovation
PatientsLikeMe, Uk

Surgeon & Founder
Myrecovery, UK

 

Experienced Solution Providers

Director of Scientific Affairs, Late Phase Services
PRA Health Sciences, UK

Download agenda here for complete speaker list

PHARMA & MEDICAL DEVICE: VPs, Directors & Managers of:

Customer Relations, Medical Affairs, Medical Science Liaisons, Medical Education, Health Outcomes & Liaison, Medical Communications, Marketing, KOL & Stakeholder Engagement, Late Phase & Real-World Research, Scientific Affairs, Medical Advisors and Patient-Centricity.

The PharmaValue Stakeholder Forum is a truly special event and unique discussion format. It focuses on the issues most critical to the future viability of the pharmaceutical industry, which has a strong track record in developing lifesaving drugs for patients. NextLevel LifeSciences is bringing together a unique mix of thought leaders from patient and doctors representatives, payers, health technology assessors, regulators and senior executives from key departments in pharma companies. There will be no presentations, but only interactive panel discussions on 5 of the most challenging areas faced by those who care passionately for medical innovation. These discussions will be:

• Stimulating Innovation in Clinical Research

• Unlocking the Potential of Real-World and Patient-Level Data

• Achieving Value-Based Patient Access

• Enhancing Patient-Centricity in Practice

• The Future of Pharma: Evolution or Revolution?

This is a must attend event for those who feel that the current model is unsustainable and who wish to brainstorm ideas with thought-leaders from all stakeholder groups. Participants who join the discussion will jointly come away with realistic and actionable insights to move towards next-generation models and best practices to accelerate innovation and satisfy patient need.

Speaker List - Day 1

CEO,
Patient View

Sector Head & Board Member – Marketing Authorization
Swissmedic, Schweizerisches, Heilmittelinstitut

Senior Vice President & Secretary General,
European Society for Person Centered Healthcare (ESPCH)

Vice President, Head Global Clinical Science &Operations
UCB

SVP, Head of Clinical Development
BTG International

Research Professor of Medicine
The University Hospital of Catania

Global Head of Real World Evidence Solutions,
Novartis

Director of Real World Evidence, Global Patient Outcomes and Real World Evidence, International
Eli Lilly and Company

Vice President of Innovation
PatientsLikeMe

Senior Medical Officer, Vice President, Global Medical Affairs
Sanofi

Scientific Director, RMEDS, Quantitative Sciences
Janssen

Director, Technical Communication and Strategy
Wolfram Research

Deputy Regional Medical Director
NHS England North

Director of Pharmacy Strategy and Clinical Integration
Horizon Blue Cross Blue Shield of New Jersey, USA

Advisor to the President Director, International Affairs
HAS, Haute Autorité de Santé, France

Honorary Industrial Ambassador in Regulatory Science
The University of Copenhagen, Denmark

Global Head Operations, Payer & Real World Evidence
AstraZeneca

Vice President, Head of Operations and Payer Intelligence, Global Market Access,
Sanofi

VP, Head of Region Europe Value Demonstration & Access
Shire International, Switzerland

Treatment Information and Access Director, Health Policy Advisor
EURORDIS

Consumer, Lead, Chair, Consumer Forum
National Cancer Research Institute

President
European Medical Association

Head Patient Relations
Bayer

Vice President, Medical Affairs
Norgine

Chief Financial Officer
UCB

Senior Vice President, Global Patient Solutions
Teva

Global Head Operations, Payer & Real World Evidence
AstraZeneca

Director General,
European Confederation of Pharmaceutical Entrepreneurs,
Partner,
NOVACOS Law, Germany

President
European Union of Private Hospitals (UEPH)

 

This session focuses on Strategic Medical Affairs Management, specifically how Medical Affairs as a function can be at the forefront of offering added-value to key external and internal stakeholders. Furthermore, how Medical Affairs can become a strategic enabler for the entire organization by facilitating strong evidence and engagement that creates clear ROI. The issue of Patient-Centricity in practice will also be examined with perspectives, approaches and case studies presented. This will provide participants with actionable insights to help implement more patient – beneficial and focused activities that put the patient at the center of everything we do.

Speaker List - Day 2

Vice President, Medical Affairs
Norgine, UK

Vice President, Global Patient Centered Outcomes and Solutions,
Sanofi, USA

Head of Medical Affairs-Primary Care & Women's Health
Merck, USA

Senior Vice President Global Patient Solutions
Teva, Netherlands

Vice President, Corporate Medical Safety Strategic Scientific Operations
Medtronic, USA

Vice President of Innovation,
PatientsLikeMe, UK

Senior Vice President & Secretary General,
European Society for Person Centered Healthcare (ESPCH),
Editor-in-Chief,
European Journal for Person Centered Healthcare & Journal of Evaluation in Clinical Practice, Spain

Consumer Lead, Chair Consumer Forum
National Cancer Research Institute, UK

President,
European Medical Association, Belgium

 

Generating real world evidence via observational studies, the use of patient registries or Investigator Initiated Trials (IITs) is one of the fastest growing areas of pharmaceutical R&D. Such post-marketing studies are becoming increasingly important as regulatory agencies demand more long-term data which demonstrates effectiveness from a clinical perspective, yet payers are also demanding evidence of economic value. The Medical Affairs unit plays a decisive role in generating this vital evidence and this stream will present solutions to the challenges companies face in generating high-quality evidence which will enable the communication of a compelling “value” argument to all external stakeholders.

Speaker List - Stream 1

Head of DCV Medical Operations
Sanofi, Japan

Senior Medical Director Germany Medical Lead Internal Medicine,
Pfizer, Germany 

Director of Scientific Affairs, Late Phase Services
PRA Health Sciences, UK

Director Global Outcomes Research,
Takeda, UK

Head of the Centre for Clinical Trials
Witten/Herdecke University, Germany

Surgeon & Founder
Myrecovery, UK

 

 

 

Medical Affairs and MSL teams are increasingly looking to implement next generation medical communication practices. They need to offer essential evidence-based information to stakeholders on demand, through a variety of classical, yet also increasingly digital channels. This stream will focus on three key aspects of medical communication. Firstly, issues such as: protocol writing for internal late-phase studies and research initiatives; working with External Experts (KOLs) to enhance publications, abstracts & posters and receiving proposals for investigator-initiated studies. The second section of this day will focus on medical/scientific communications, including the review process, compliance issues, ensuring the claims made by marketing colleagues are justified and appropriately communicated and also effectively localized from global-level to country-level market requirements. The third area is looking at how the MSL can best be at the forefront of communicating the value message and engaging KOLs and other stakeholders.

Speaker List - Stream 2

Director, Medical Science
Valeant Pharmaceuticals, USA

Associate Director Global Medical Communications
Shire, Switzerland

Regional Medical Director, Emerging Growth Markets
Novartis, Switzerland

Director, Global Medical Information,
Biogen, Switzerland

Medical Lead for Diabetology and Cardiovascular Portfolio, CEE Region
MSD, Poland

EU Medical Director,
Norgine, UK

Medical Director
BMS, Romania

 

This session focuses on the fast-evolving role of Medical Affairs specifically for MedTech companies and the increasingly important need for this function which facilitates overall corporate performance. The different business model of MedTech vs Pharma, necessitates an adjustment in the way KOLs, external experts & patients are engaged with and communicated to. This highly-popular, 1-day stream is back and with new speakers, will enable the MedTech community to get the most out of their Medical Affairs teams and develop a more patient-centric business model.

Speaker List - Day 4, Option A

Medical Affairs Lead, Medical Devices EMEA
Johnson & Johnson, UK

Director, Medical Affairs, Structural Heart EMEA
Abbott Vascular, Belgium

Vice President, Corporate Medical Safety Strategic Scientific Operations
Medtronic, USA

Global Scientific Communications Director, Medical Affairs
Medtronic, France

Head of Clinical Science Support,
Geistlich, Switzerland 

Surgeon & Founder
Myrecovery, UK

This one-day workshop will take participants through the strategic medical communications planning process step-by-step. We will present theory and best practice around a number of aspects of communications planning and programme development. At each stage, participants will then work together on an example scenario to discuss and develop their own ideas with support from our experts. There will be plenty of opportunity for questions and discussion.

Workshop presented by: 

 

 

Workshop will be led by:

Jennifer van Zwieten,
Director of Scientific Services,
Succinct Medical Communications

Jennifer Chilver,
Strategy Director,
Succinct Medical Communications, UK

This event will provide all delegates the chance to meet one another through our many networking opportunities. With pre-event, mid-morning and mid-afternoon breaks as a standard, this event will also feature a complimentary networking dinner for all participants.

This evening will allow you to meet with our expert speaker panel who represent many stakeholder groups in a less formal setting. Our networking lunches will also allow you plenty of time to meet with your peers and colleagues whilst you refuel through the event.

RECEIVE DISCOUNTED FLIGHTS WHEN YOU REGISTER FOR THIS EVENT WITH

This event is accredited for CPD (Continuing Professional Development) status

Share with Colleagues